ARCHIVES

Nexavar Improves PFS In HER-2 Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts

June 30, 1989

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

IOM Selects Advisors To Defense Department

February 5, 1993